|
1
|
Fine HA, Dear KB, Loeffler JS, Black PM
and Canellos GP: Meta-analysis of radiation therapy with and
without adjuvant chemotherapy for malignant gliomas in adults.
Cancer. 71:2585–2597. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wu X, Li Y, Wan X, Kayira TM, Cao R, Ju X,
Zhu X and Zhao G: Down-regulation of neogenin accelerated glioma
progression through promoter Methylation and its overexpression in
SHG-44 Induced Apoptosis. PLoS One. 7:e380742012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Van Meir EG, Hadjipanayis CG, Norden AD,
Shu HK, Wen PY and Olson JJ: Exciting new advances in
neuro-oncology: The avenue to a cure for malignant glioma. CA
Cancer J Clin. 60:166–193. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Turbyville TJ, Gürsel DB, Tuskan RG,
Walrath JC, Lipschultz CA, Lockett SJ, Wiemer DF, Beutler JA and
Reilly KM: Schweinfurthin A selectively inhibits proliferation and
Rho signaling in glioma and neurofibromatosis type 1 tumor cells in
a NF1-GRD-dependent manner. Mol Cancer Ther. 9:1234–1243. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ohgaki H and Kleihues P: Epidemiology and
etiology of gliomas. Acta Neuropathol. 109:93–108. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Schwartzbaum JA, Fisher JL, Aldape KD and
Wrensch M: Epidemiology and molecular pathology of glioma. Nat Clin
Pract Neurol. 2:494–503. 2006.quiz 491 p following 516. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gross B, Gaestel M, Böhm H and Bielka H:
cDNA sequence coding for a translationally controlled human tumor
protein. Nucleic Acids Res. 17:83671989. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chung S, Kim M, Choi W, Chung J and Lee K:
Expression of translationally controlled tumor protein mRNA in
human colon cancer. Cancer Lett. 156:185–190. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bazile F, Pascal A, Arnal I, Le Clainche
C, Chesnel F and Kubiak JZ: Complex relationship between TCTP,
microtubules and actin microfilaments regulates cell shape in
normal and cancer cells. Carcinogenesis. 30:555–565. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang F, Liu B, Wang Z, Yu XJ, Ni QX, Yang
WT, Mukaida N and Li YY: A novel regulatory mechanism of Pim-3
kinase stability and its involvement in pancreatic cancer
progression. Mol Cancer Res. 11:1508–1520. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu LK, Wu HF, Guo ZR, Chen XJ, Yang D,
Shu YQ and Zhang JN: Targeted efficacy of dihydroartemisinin for
transla-tionally controlled protein expression in a lung cancer
model. Asian Pac J Cancer Prev. 15:2511–2515. 2014. View Article : Google Scholar
|
|
12
|
Cans C, Passer BJ, Shalak V,
Nancy-Portebois V, Crible V, Amzallag N, Allanic D, Tufino R,
Argentini M, Moras D, et al: Translationally controlled tumor
protein acts as a guanine nucleotide dissociation inhibitor on the
translation elongation factor eEF1A. Proc Natl Acad Sci USA.
100:13892–13897. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gachet Y, Tournier S, Lee M,
Lazaris-Karatzas A, Poulton T and Bommer UA: The growth-related,
translationally controlled protein P23 has properties of a tubulin
binding protein and associates transiently with microtubules during
the cell cycle. J Cell Sci. 112:1257–1271. 1999.PubMed/NCBI
|
|
14
|
Liu H, Peng HW, Cheng YS, Yuan HS and
Yang-Yen HF: Stabilization and enhancement of the antiapoptotic
activity of mcl-1 by TCTP. Mol Cell Biol. 25:3117–3126. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nagano-Ito M and Ichikawa S: Biological
effects of Mammalian translationally controlled tumor protein
(TCTP) on cell death, proliferation and tumorigenesis. Biochem Res
Int. 2012:2049602012. View Article : Google Scholar
|
|
16
|
Li F, Zhang D and Fujise K:
Characterization of fortilin, a novel antiapoptotic protein. J Biol
Chem. 276:47542–47549. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Miao X, Chen YB, Xu SL, Zhao T, Liu JY, Li
YR, Wang J, Zhang J and Guo GZ: TCTP overexpression is associated
with the development and progression of glioma. Tumour Biol.
34:3357–3361. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gu X, Yao L, Ma G, Cui L, Li Y, Liang W,
Zhao B and Li K: TCTP promotes glioma cell proliferation in vitro
and in vivo via enhanced β-catenin/TCF-4 transcription. Neuro
Oncol. 16:217–227. 2014. View Article : Google Scholar :
|
|
19
|
Acunzo J, Baylot V, So A and Rocchi P:
TCTP as therapeutic target in cancers. Cancer Treat Rev.
40:760–769. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lucibello M, Gambacurta A, Zonfrillo M,
Pierimarchi P, Serafino A, Rasi G, Rubartelli A and Garaci E: TCTP
is a critical survival factor that protects cancer cells from
oxidative stress-induced cell-death. Exp Cell Res. 317:2479–2489.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Graidist P, Phongdara A and Fujise K:
Antiapoptotic protein partners fortilin and MCL1 independently
protect cells from 5-fluorouracil-induced cytotoxicity. J Biol
Chem. 279:40868–40875. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2 (-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
23
|
Chan TH, Chen L and Guan XY: Role of
translationally controlled tumor protein in cancer progression.
Biochem Res Int. 2012:3693842012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tuynder M, Fiucci G, Prieur S, Lespagnol
A, Géant A, Beaucourt S, Duflaut D, Besse S, Susini L, Cavarelli J,
et al: Translationally controlled tumor protein is a target of
tumor reversion. Proc Natl Acad Sci USA. 101:15364–15369. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen SH, Wu PS, Chou CH, Yan YT, Liu H,
Weng SY and Yang-Yen HF: A knockout mouse approach reveals that
TCTP functions as an essential factor for cell proliferation and
survival in a tissue-or cell type-specific manner. Mol Biol Cell.
18:2525–2532. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhu WL, Cheng HX, Han N, Liu DL, Zhu WX,
Fan BL and Duan FL: Messenger RNA expression of translationally
controlled tumor protein (TCTP) in liver regeneration and cancer.
Anticancer Res. 28:1575–1580. 2008.PubMed/NCBI
|
|
27
|
Hsiao YC, Hsieh YS, Kuo WH, Chiou HL, Yang
SF, Chiang WL and Chu SC: The tumor-growth inhibitory activity of
flavanone and 2′-OH flavanone in vitro and in vivo through
induction of cell cycle arrest and suppression of cyclins and CDKs.
J Biomed Sci. 14:107–119. 2007. View Article : Google Scholar
|
|
28
|
Ayyagari VN and Brard L: Bithionol
inhibits ovarian cancer cell growth in vitro-studies on
mechanism(s) of action. BMC Cancer. 14:612014. View Article : Google Scholar
|
|
29
|
He L, Lu N, Dai Q, Zhao Y, Zhao L, Wang H,
Li Z, You Q and Guo Q: Wogonin induced G1 cell cycle arrest by
regulating Wnt/β-catenin signaling pathway and inactivating CDK8 in
human colorectal cancer carcinoma cells. Toxicology. 312:36–47.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jung J, Kim HY, Maeng J, Kim M, Shin DH
and Lee K: Interaction of translationally controlled tumor protein
with Apaf-1 is involved in the development of chemoresistance in
HeLa cells. BMC Cancer. 14:1652014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Susini L, Besse S, Duflaut D, Lespagnol A,
Beekman C, Fiucci G, Atkinson AR, Busso D, Poussin P, Marine JC, et
al: TCTP protects from apoptotic cell death by antagonizing bax
function. Cell Death Differ. 15:1211–1220. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wu D, Guo Z, Min W, Zhou B, Li M, Li W and
Luo D: Upregulation of TCTP expression in human skin squamous cell
carcinoma increases tumor cell viability through anti-apoptotic
action of the protein. Exp Ther Med. 3:437–442. 2012.PubMed/NCBI
|
|
33
|
Rho SB, Lee JH, Park MS, Byun HJ, Kang S,
Seo SS, Kim JY and Park SY: Anti-apoptotic protein TCTP controls
the stability of the tumor suppressor p53. FEBS Lett. 585:29–35.
2011. View Article : Google Scholar
|
|
34
|
Kaarbo M, Storm ML, Qu S, Wæhre H, Risberg
B, Danielsen HE and Saatcioglu F: TCTP is an androgen-regulated
gene implicated in prostate cancer. PLoS One. 8:e693982013.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Nakopoulou L, Tsirmpa I, Alexandrou P,
Louvrou A, Ampela C, Markaki S and Davaris PS: MMP-2 protein in
invasive breast cancer and the impact of MMP-2/TIMP-2 phenotype on
overall survival. Breast Cancer Res Treat. 77:145–155. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Luo Y, Liang F and Zhang ZY: PRL1 promotes
cell migration and invasion by increasing MMP2 and MMP9 expression
through Src and ERK1/2 pathways. Biochemistry. 48:1838–1846. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chu ZH, Liu L, Zheng CX, Lai W, Li SF, Wu
H, Zeng YJ, Zhao HY and Guan YF: Proteomic analysis identifies
translationally controlled tumor protein as a mediator of
phosphatase of regenerating liver-3-promoted proliferation,
migration and invasion in human colon cancer cells. Chin Med J
(Engl). 124:3778–3785. 2011.
|
|
38
|
Ma Q, Geng Y, Xu W, Wu Y, He F, Shu W,
Huang M, Du H and Li M: The role of translationally controlled
tumor protein in tumor growth and metastasis of colon
adenocarcinoma cells. J Proteome Res. 9:40–49. 2010. View Article : Google Scholar
|
